• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度北部一家三级护理医院中勃起功能障碍与下尿路症状之间的关联

Association Between Erectile Dysfunction and Lower Urinary Tract Symptoms in a North Indian Tertiary Care Hospital.

作者信息

Gyani Rishikant, Goel Apul, Sankhwar Satyanarayan, Singh Bhupendra P, Kumar Manoj, Singh Vivek Kumar

机构信息

Urology, King George's Medical University, Lucknow, IND.

Urology, Institute of Medical Sciences, Varanasi, IND.

出版信息

Cureus. 2025 Jun 4;17(6):e85352. doi: 10.7759/cureus.85352. eCollection 2025 Jun.

DOI:10.7759/cureus.85352
PMID:40621335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12227428/
Abstract

Introduction This study aimed to investigate the relationship between erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) in a North Indian population, as well as to assess the influence of age, serum prostate-specific antigen (PSA), and testosterone levels on this association. Materials and methods A cross-sectional study was conducted at King George's Medical University, Lucknow, India, involving 183 men aged ≥50 years presenting with LUTS or benign prostatic hyperplasia (BPH). The severity of ED was assessed using the International Index of Erectile Function-15 (IIEF-15), while LUTS severity was measured using the International Prostate Symptom Score (IPSS). Serum PSA and testosterone levels were evaluated. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 26.0 (Released 2018; IBM Corp., Armonk, NY, United States), with a significance level set at p < 0.05. Results The patients' mean ± SD age was 63.13 ± 8.98 years. The severity of LUTS was classified as mild in 67 patients (36.6%), moderate in 62 (33.8%), and severe in 54 (29.5%). ED was categorized as mild in 92 patients (50.3%), moderate in 73 (39.9%), and severe in 18 (9.8%). A significant correlation was found between ED severity and increasing age (p < 0.001), as well as with higher IPSS (p < 0.05). Additionally, ED was significantly associated with comorbidities, including hypertension (HTN) and diabetes mellitus (DM) (p < 0.05). Furthermore, IIEF-15 scores showed a significant correlation with testosterone levels (r = 0.679, p < 0.001). No significant correlation was found between ED severity and serum PSA levels. Conclusions This study found a significant association between ED and the severity of LUTS in men with BPH. The data revealed that patients over 79 years of age tended to have lower testosterone levels, and the presence of comorbidities such as HTN and DM emerged as major risk factors for ED. These findings highlight the significance of adopting a comprehensive, multifactorial approach to assess and manage ED in patients with LUTS.

摘要

引言 本研究旨在调查印度北部人群中勃起功能障碍(ED)与下尿路症状(LUTS)之间的关系,并评估年龄、血清前列腺特异性抗原(PSA)和睾酮水平对这种关联的影响。

材料与方法 在印度勒克瑙的乔治国王医科大学进行了一项横断面研究,纳入了183名年龄≥50岁且有LUTS或良性前列腺增生(BPH)的男性。使用国际勃起功能指数-15(IIEF-15)评估ED的严重程度,同时使用国际前列腺症状评分(IPSS)测量LUTS的严重程度。评估血清PSA和睾酮水平。使用IBM SPSS Statistics for Windows 26.0版(2018年发布;IBM公司,美国纽约州阿蒙克)进行统计分析,显著性水平设定为p<0.05。

结果 患者的平均年龄±标准差为63.13±8.98岁。LUTS严重程度分类为轻度的有67例患者(36.6%),中度的有62例(33.8%),重度的有54例(29.5%)。ED分类为轻度的有92例患者(50.3%),中度的有73例(39.9%),重度的有18例(9.8%)。发现ED严重程度与年龄增加(p<0.001)以及较高的IPSS(p<0.05)之间存在显著相关性。此外,ED与包括高血压(HTN)和糖尿病(DM)在内的合并症显著相关(p<0.05)。此外,IIEF-15评分与睾酮水平显示出显著相关性(r = 0.679,p<0.001)。未发现ED严重程度与血清PSA水平之间存在显著相关性。

结论 本研究发现BPH男性中ED与LUTS严重程度之间存在显著关联。数据显示,79岁以上的患者睾酮水平往往较低,而HTN和DM等合并症的存在是ED的主要危险因素。这些发现凸显了采用综合、多因素方法评估和管理LUTS患者ED的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a96/12227428/fca2e4b6e09a/cureus-0017-00000085352-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a96/12227428/fca2e4b6e09a/cureus-0017-00000085352-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a96/12227428/fca2e4b6e09a/cureus-0017-00000085352-i01.jpg

相似文献

1
Association Between Erectile Dysfunction and Lower Urinary Tract Symptoms in a North Indian Tertiary Care Hospital.印度北部一家三级护理医院中勃起功能障碍与下尿路症状之间的关联
Cureus. 2025 Jun 4;17(6):e85352. doi: 10.7759/cureus.85352. eCollection 2025 Jun.
2
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.男性良性前列腺增生症下尿路症状的微创治疗:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jul 15;7(7):CD013656. doi: 10.1002/14651858.CD013656.pub2.
3
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.经尿道前列腺动脉栓塞术治疗良性前列腺增生症男性下尿路症状。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD012867. doi: 10.1002/14651858.CD012867.pub3.
4
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis.男性下尿路症状与心血管事件:系统评价和荟萃分析。
Eur Urol. 2016 Nov;70(5):788-796. doi: 10.1016/j.eururo.2016.07.007. Epub 2016 Jul 20.
5
The Relationship Between Immune-Inflammatory Indexes and the Severity of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Cross-Sectional Study at a Tertiary Hospital in China.免疫炎症指标与下尿路症状/良性前列腺增生严重程度的关系:中国一家三级医院的横断面研究
J Inflamm Res. 2025 Jun 27;18:8509-8523. doi: 10.2147/JIR.S523193. eCollection 2025.
6
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.一项关于单独使用磷酸二酯酶 5 抑制剂或与α受体阻滞剂联合治疗良性前列腺增生所致下尿路症状的系统评价和荟萃分析。
Eur Urol. 2012 May;61(5):994-1003. doi: 10.1016/j.eururo.2012.02.033. Epub 2012 Feb 25.
7
Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.经尿道微波热疗与前列腺动脉栓塞术治疗良性前列腺增生症患者严重下尿路症状的非劣效性、随机、开放标签临床试验:TUMT-PAE-1 试验研究方案。
Trials. 2024 Sep 2;25(1):574. doi: 10.1186/s13063-024-08409-x.
8
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.
9
Pygeum africanum for benign prostatic hyperplasia.非洲臀果木治疗良性前列腺增生症。
Cochrane Database Syst Rev. 2002;1998(1):CD001044. doi: 10.1002/14651858.CD001044.
10
Finasteride for benign prostatic hyperplasia.非那雄胺用于良性前列腺增生症。
Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD006015. doi: 10.1002/14651858.CD006015.pub3.

本文引用的文献

1
Prevalence and associated factors of moderate to severe erectile dysfunction among adult men in Malaysia.马来西亚成年男性中中重度勃起功能障碍的流行情况及相关因素。
Sci Rep. 2023 Dec 6;13(1):21483. doi: 10.1038/s41598-023-48778-y.
2
Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward.印度新冠疫情期间的结核病:潜在挑战与未来之路
Trop Med Health. 2021 Oct 21;49(1):84. doi: 10.1186/s41182-021-00377-1.
3
No Benefit of Hemostatic Drugs on Acute Upper Gastrointestinal Bleeding in Cirrhosis.肝硬化急性上消化道出血中止血药物无效。
Biomed Res Int. 2020 Jun 26;2020:4097170. doi: 10.1155/2020/4097170. eCollection 2020.
4
Associations between lifestyle, erectile dysfunction and healthcare seeking: a population-based study.生活方式、勃起功能障碍与就医寻求之间的关联:基于人群的研究。
Scand J Prim Health Care. 2020 Jun;38(2):176-183. doi: 10.1080/02813432.2020.1753347. Epub 2020 Apr 21.
5
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?勃起功能障碍作为心血管风险因素:是时候采取行动了吗?
Curr Vasc Pharmacol. 2021;19(3):301-312. doi: 10.2174/1570161118666200414102556.
6
Correlation Analysis of Erectile Dysfunction with Lower Urinary Tract Symptoms (LUTS) Degree and Clinical Features in LUTS Patients.下尿路症状(LUTS)患者勃起功能障碍与LUTS严重程度及临床特征的相关性分析
Iran J Public Health. 2018 May;47(5):658-665.
7
Prevalence of erectile dysfunction in Egyptian males with metabolic syndrome.埃及患有代谢综合征男性的勃起功能障碍患病率。
Aging Male. 2020 Dec;23(4):257-263. doi: 10.1080/13685538.2018.1479736. Epub 2018 Jun 19.
8
Prevalence and predictors of erectile dysfunction in adult male outpatient clinic attendees in Johor, Malaysia.马来西亚柔佛州成年男性门诊患者勃起功能障碍的患病率及预测因素
Singapore Med J. 2019 Jan;60(1):40-47. doi: 10.11622/smedj.2018049. Epub 2018 May 18.
9
Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.下尿路症状/良性前列腺增生与勃起功能障碍的流行病学及危险因素
Aging Male. 2019 Mar;22(1):12-19. doi: 10.1080/13685538.2018.1434772. Epub 2018 Feb 2.
10
Erectile Dysfunction and Lower Urinary Tract Symptoms.勃起功能障碍与下尿路症状。
Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27.